Financials
- Market Capitalization 150.67 M
- Employee 29
- Founded 2015
- CEO N/A
- Website nrxpharma.com
- Headquarter Delaware, United States
- FIGI BBG00JCWDN63
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-5.59
ratio cours/chiffre d'affaires
34.34
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3737 | OTLK Outlook Therapeutics, Inc. - Common Stock | 0.63 USD | -1.56% | +3.28% | -34.37% | +52.73% | 153.37 M USD | ||
| 3738 | INDP Indaptus Therapeutics, Inc. - Common Stock | 1.15 USD | +0.88% | 0.00% | -12.88% | -39.47% | 153.23 M USD | ||
| 3749 | ADCT ADC Therapeutics SA Common Shares | 1.17 USD | +2.63% | +18.18% | +9.35% | -62.14% | 149.37 M USD | ||
| 3764 | UNCY Unicycive Therapeutics, Inc. - Common Stock | 5.20 USD | -1.33% | -3.70% | +4.00% | -20.12% | 144.85 M USD |